These outcomes, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 support the notion of targeting ACKR3 as a novel approach to modulate the opioid method, which could open up new therapeutic avenues for opioid-relevant Conditions. A fresh research shows the https://henryz061ulb7.wikicorrespondence.com/user